Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).

Saved in:
Bibliographic Details
Title: Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
Authors: Kizub DA; The Everett Clinic, Everett, WA, USA. daryakizub@gmail.com., Miao J; SWOG Statistical Center, Seattle, WA, USA., Schubert MM; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; University of Washington School of Dentistry, Seattle, WA, USA., Paterson AHG; Tom Baker Cancer Center, Calgary, Alberta, Canada., Clemons M; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Dees EC; University of North Carolina, Chapel Hill, NC, USA., Ingle JN; Mayo Clinic, Rochester, MN, USA., Falkson CI; Wilmot Cancer Center at the University of Rochester, Rochester, NY, USA., Barlow WE; SWOG Statistical Center, Seattle, WA, USA., Hortobagyi GN; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gralow JR; University of Washington School of Medicine, Seattle, WA, USA.
Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 May; Vol. 29 (5), pp. 2509-2517. Date of Electronic Publication: 2020 Sep 15.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1433-7339
DOI:10.1007/s00520-020-05748-8